 |
|
|
| |
Response-Guided Therapy with DAA Shortens Treatment Duration in 50% of HCV Treated Patients
|
| |
| |
Reported by Jules Levin
AASLD 2018 Nov 9-13 SF
Ohad Etzion1*, HarelDahari2*, David Yardeni1, AssafIssachar3, AnatNevo-Shor1, Michal Cohen-Naftaly3, Susan L. Uprichard2, OrlySnehArbib3, Daniela Munteanu1, Marius Braun3, Scott J. Cotler2, NaimAbufreha1, Orna Mor4, Amir Shlomai3
1The Department of Gastroenterology and Liver Diseases, SorokaUniversity Medical Center, BeerSheba, Israel.2 The Program for Experimental & Theoretical Modeling, Division of Hepatology, Department of Medicine, Loyola University Chicago, Maywood, IL, USA. 3Department of Medicine D and The Liver Institute, Rabin Medical Center, BeilinsonHospital, Petah-Tikva, Israel. 4 Central Virology Laboratory, Ministry of Health, Sheba Medical Center, Israel
* Equal contributors (Ohadet34@yahoo.com; Harel.dahari@gmail.com)
|
| |
|
|
|
|
|
